Dhara B. WaghelaAssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comConnectEmail424-288-5331 Professional Biography Dhara Waghela is an associate in the Corporate Practice Group in the firm's Century City office and is a member of the firm’s Healthcare team. More Legal and Business Bylines From Dhara B. Waghela Do Your Medical Director Arrangements Meet the Top Five Best Practices? - (Posted On Thursday, June 15, 2023) PE Firms Face Liability for the Conduct of their Portfolio Companies: Are you Paying Attention? - (Posted On Monday, April 03, 2023) Putting the Brakes on Healthcare M&A and Provider/Payor Contracting: AB 2080 Poised to Dramatically Impact Healthcare Transactions in California - (Posted On Thursday, July 07, 2022) HIPAA and COVID-19 Vaccination Status: The Office of Civil Rights Issues Workplace Guidance - (Posted On Wednesday, October 13, 2021) Executive Order on Promoting Competition in the American Economy: The Biden Administration Considers Drug Pricing Strategies While Keeping the “Most Favored Nations” Drug Reimbursement Program on the Sidelines - (Posted On Friday, August 20, 2021) The American Rescue Plan Act of 2021: A New Lease on Life for the Affordable Care Act? - (Posted On Friday, March 26, 2021) Medicare Part B Most Favored Nation Drug Pricing Model: New Rules, New Lawsuits, New Tweets - (Posted On Monday, December 21, 2020) ERISA: The Erosion of State Health Regulation Rights - (Posted On Wednesday, November 04, 2020) The Death of RBG…and the ACA? - (Posted On Friday, September 25, 2020) The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry - (Posted On Friday, September 18, 2020) Pagination Page 1 Next page Next › Current Legal Analysis Detour Ahead: New Approach to Assessing Prior Art Rejections Under § 102(e) by: Benjamin N. Ediger, PhD Hatch-Waxman Litigation Expenses Are Deductible Under Internal Revenue Code § 162(a) by: Intellectual Property Practice Group Court Sides with RICO Complainant Who Received Tainted Medical Marijuana and with FDA on Regulating E-Cigarettes - SCOTUS Today by: Stuart M. Gerson The Clear and Unmistakable Standard for Applying Prosecution Disclaimer by: Sarah Mezini Using International Arbitration to Resolve Retaliatory Tariff Disputes in Global Supply Chains by: Frederick A. Acomb , James L. Woolard CSRD and CSDDD Officially Delayed, With Huge Majority of MEPs in Support by: John Verwey , Rachel E. Lowe Tempus Fugit Ad Nevada by: Keith Paul Bishop President Trump Announces "Reciprocal" Tariffs Beginning 5 April 2025 by: Nathaniel B. Bolin , David R. Allman Supreme Court Rules Lost Wages May Be Recoverable Under RICO For False Advertising After Drug Test Dismissal by: Bruce J. Douglas , Maria B. Shatonova Wyoming Bans Most Non-Compete Agreements by: Steven J Pearlman , Sehreen Ladak USCIS Announces Initial FY 2026 H-1B Cap Selection: What Employers Need to Do Next by: Jessica K. Lang SEC Provides Further Clarity in Rule 506(c) Offerings by: Daniel I. DeWolf , Samuel Asher Effron FedRAMP 20x – Major Overhaul Announced to Streamline the Security Authorization Process for Government Cloud Offerings by: Townsend L. Bourne , Daniel J. Alvarado USDA Will Fund 543 Projects in 29 States Through Higher Blends Infrastructure Incentive Program by: Lynn L. Bergeson , Carla N. Hutton Immigration Enforcement and Healthcare Facilities: Key Considerations for Providers by: Lotan Barbaresso , Amy J. Dilcher Upcoming Events Apr 30 2025 Workplace Horizons 2025 Apr 3 2025 Defense Counsel: Obligations to Insured Clients and Insurers Apr 3 2025 Defense Counsel: Obligations to Insured Clients and Insurers Apr 7 2025 Understanding the Basics of a Class Action Print
